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THERE are now reports of pituitary ablation in over 2000 women with breast
cancer. In most of these the pituitary has been removed through a frontal
craniotomy; in others the pituitary has been irradiated either externally or by
implantation of radioactive substances; and in a minority the pituitary was
removed through a paranasal approach, a procedure in which damage to the
optic and olfactory nerves and the brain substance has largely been avoided. This
operation of trans-sphenoidal hypophysectomy was begun in Bristol in March
1960 and by the end of 1966, 324 women with advanced breast cancer had been
so treated by one of us (J.A.J.). This is the largest group reported of patients
treated in this way. By January, 1965, 258 women had been treated by this
operation, and this paper records a follow up study of these cases which was
closed 6 months later in July, 1965.
The patients were unselected, provided that it seemed that they would survive
the operation.
Operative technique
The pituitary gland was removed using the Chiari trans-ethmosphenoidal
combined with the trans-nasal approach (James, 1964). As clear a view as
possible has been obtained of the recesses of the fossa with the aim of removing
every fragment ofthe gland. No attempt has been made to ablate any remaining
pituitary tissue with Zenker's solution.
In the earliest cases post-operative cerebrospinal leakage, with its accompany-
ing risk of meningitis, was relatively common; but this complication has been
largely avoided by fascia and muscle sandwich packing: the operculum in the
diaphragm sellae is sealed offwith a disc offascia lata; the pituitary fossa is then
filled with muscle graft thus retaining the fascia in place, and the bony aperture
in the anterior wall ofthe sella is closed by returning the mucous membrane ofthe
sphenoidal sinus or covering the aperture with a further patch of fascia lata.
Thepatients were given 200 mg. cortisone acetate 24hours before the operation,
200 mg. intra-muscularly 1 hour before operation, and 100 mg. intra-muscularly
on returning to the ward. They were discharged from hospital taking 75 mg.
daily.
A previous adrenalectomy did not cause special difficulties at hypophysectomy.
In one, who had extensive abdominal metastases and jaundice, there was vomiting,
hypotension and electrolyte disturbance which required prolonged intravenous
treatment; 11 other patients who had had adrenalectomy had an uneventful
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Post-operative follow-up
Surviving patients were followed in the Ear Nose and Throat Outpatient
Department where progress of the cancer was recorded and in the Endocrine
Clinic where hormone replacement treatment was controlled. The dose of
cortisone was adjusted to the clinical needs of each patient. Thyroxine was
prescribed when clinical evidence of the hypothyroidism developed. Pitressin
tannate, in oil by injection, pituitary snuff or syntopressin nasal spray have been
used to control diabetes insipidus. Patients who either did not respond to
hypophysectomy or later relapsed were given radiotherapy, or any other treatment
needed, including the use of hormone preparations.
COMPLICATIONS OF HYPOPHYSECTOMY
TABLE I.-The Complication.s of Hypophysectomy in 258 Cases
Meningitis . 13
C.S.F. leakage . 32
Persistant anosmia . 8
Immediate diabetes insipidus . 129
Operative haemorrhage 15
Excessive weight gain . 8
Unilateral blindness . 2
Leakage of cerebrospinalfluid.-Thirty-two women had post operative leakage
of cerebrospinal fluid (C.S.F.) from the nose. Of these, 8 (or 25%) had cerebral
metastases, and two more developed signs of cerebral metastases soon after
hypophysectomy. Of 6 patients recorded as having papilloedema, 3 developed
leakage of C.S.F. after operation. Eight of the women with leakage of C.S.F.
developed meningitis causing the death of 2. In 4 women a second operation was
required to stop the leakage. Thus brain metastases and papilloedema add to the
risk and technical difficulties of hypophysectomy; but with the improved tech-
nique there has been a lower incidence of leakage: in the first 3 years it was 16%
and for the last 2 years it has been only 5-6%.
Meningitis.-Meningitis occurred in 13 patients, 8 of whom also had a leakage
of C.S.F. and 5 of them died of meningitis. Three of the women developed
meningitis during an epidemic of influenza. Ten women developed meningitis
within 1 month of hypophysectomy and 3 more than 1 month after hypophysec-
tomy, only 1 of these 3 having a persistent leakage of C.S.F.
Haemorrhage.-Cavernous sinus haemorrhage caused abandonment of a first
operation in 6 cases. All ofthese had a successful second operation. Nine others
bled from the operation site, one requiring a 21 pint blood transfusion. None of
those who bled developed meningitis.
Unilateral blindness.-One of the patients who bled became blind in 1 eye at
operation and was later found to have a carotido-cavernous fistula for which the
carotid artery was later ligated. Another women became blind in 1 eye at
operation and later developed the appearance ofoptic atrophy in that eye. It was
likely in this case that the optic nerve was damaged at the time of diathermy
coagulation of the anterior ethmoidal artery.
Anosmia.-Eight women complained of loss or impairment of the sense of
smell which persisted after hypophysectomy.
Diabetes insipidus.-If the urine exceeded 3 litres in any 24 hours within 2
weeks of hypophysectomy this has been called " immediate diabetes insipidus ".
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This occurred in 50% ofpatients; between 20 and 39 years old 75% were affected,
but only 22% in those of 70 years or more.
Forty-eight patients were given pitressin for more than 3 months after hypo-
physectomy. At least 12 received pitressin for more than 6 months and 6 for more
than 1 year. One patient was still using pitressin 44 months after hypophysec-
tomy. The use of pitressin at any time shows the same correlation with age as
does the incidence of " immediate diabetes insipidus ". (Table II).
TABLE II.-Relationship Between Age and Diabetes Insipidus
Age
(years)
20-39
40-49
50-59
60-69
70+
Incidence of
" immediate D.I. "
75
66
45
42
22
Pitressin used
at any time
75
67
63
55
35
Obesity.-Eight women gained much weight post-operatively, over 3 stones in
6 months in 2 of them.
RESULTS
The effects ofoperation have been studied by judging clinical improvement and
regression of deposits on the one hand, and by length of life on the other. For
various reasonswe have chosen, forthe purposes ofthis report, to use the " survival
time ". This involved coding details on Hollerith punch cards and calculating
survival tables using an Elliott 503 computer.
Survival ofthe whole group.-In Table III it can be seen that in the actual group
studied, 49% survive 6 months, 30.7% survive 1 year, 18-4% 18 months, and 11.9%
2 years.
TABLE III.-Survival Tablefor the Whole Group
Time intervals
after treatment
(months)
0
1
3
6
9
12
15
18
21
24
30
36
48+
Probability of
surviving
each interval
0 872
0 735
0-764
0 754
0 829
0*821
0-731
0 829
0 778
0 684
0-818
0-250
Number alive at beginning
of each interval
out of 1000 patients
1000
872
641
490
370
307
252
184
152
119
81
66
17
The survival table expresses the rate ofdeath ofa theoretical population of 1000 patients ifexpose d
to the same probability of dying, during intervals covering the period of study, as in the actual
population of 258 women being studied. Patients who are lost to follow up or who are known to be
alive but have not been followed for the maximum period are included in the table for their known
follow up period and then withdrawn from the number of patients at risk of dying in the subsequent
interval. By this means, maximum use is made of the available information on survival. All
figures for survival after hypophysectomy that follow have been calculated in this way.
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Operative mortality.-Within 3 weeks of hypophysectomy 26 women (10%)
died and by 1 month 9 others had died (13.6% in all); most ofthese deaths during
the first month were seemingly due to the neoplastic process. But a total of
15 patients died of causes that were to a greater or less extent associated with the
operation; thus as mentioned earlier 5 died with meningitis (3 ofthese more than
1 month after operation), 3 had pulmonary emboli and 2 bronchopneumonia.
Five other patients died on the very day of their operation: two of these had
severe dyspnoea at rest pre-operatively and died of respiratory failure, 1 died
after inhaling a blood clot, one 76 year old woman collapsed and died a few hours
after operation, another woman who had papilloedema died shortly after returning
to the ward. If all of these 15 deaths are attributed to the operation then the
operative mortality is 5.8%.
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FIG. I.-A graph of the chance ofsurviving each three month interval after hypophy-sectomy.
During the first 3 months, 92 patients died (including the 35 mentioned above)
and in only 7 of these was there any recorded improvement in the symptoms or
signs of their cancer lasting for more than a month, in other words nearly all the
patients dying within the first 3 months had failed to respond to hypophysectomy.
Subrvival after 3 mnonth8.-After the first 3 months the chance of surviving
improved. There is no evidence that escape from the therapeutic effects of
hypophysectomy occurs at any one time during the first 33 months after operation
(Fig. 1).
FACTORS AFFECTING OUTCOME
Groups of the patients have belen selected to study the relationship between
survival and various pre- and post-operative factors, using figures at 1 year.
These have been derived from separate survival tables for each group.' Survival
figures at 18 months have also been examined and in no case were they found to
show a trend different from one yearfigures, nor were anysignificant facts revealed
that were not present in the one year survival figures.
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Pre-Operative Factors
The association of some pre-operative factors and survival rates at 1 year later
are shown in Table IV: column B gives the calculated chances of survival for 12
months; the subsequent columns provide the basis from which statistical signifi-
ances are derived.
Free interval.-The interval between discovery of the primary tumour and the
first evidence of metastases has been called the " free interval " (Editorial, 1960).
It is generally recognised that the longer the free interval, the better is the chance
of a good response to hypophysectomy. Of those patients with a free interval of
less than 1 year 23% survive 1 year; and ofthose with a free interval of 5 years or
more nearly 50% survive 1 year.
Menstrual history.-There were 24 women still menstruating until hypophysec-
tomy; a year later 29% were still alive. Periods had stopped less than 3 years
previously in 47 women; and only 17% were still alive a year later: menopause
however had been spontaneous in only 8 of these 47 women; thirty-four had had
oophorectomy, and 10 of these were recorded as having had subsequent tumour
regression; one had irradiation of the ovaries, and 4 stopped menstruating as a
result of androgen treatment. Of the 8 with spontaneous menopause all were
followed until death and only 1 survived more than 5 months.
In 127 women menopause had occurred over 3 years earlier and of these
patients 40% were still alive a year after hypophysectomy. Ofthese 127 patients
only 19 had had oophorectomy.
The 1 year survival ofpatients whose menopause was more than 5 years before
hypophysectomy was 39.2%. This is the same as that for patients whose meno-
pause was more than 3 years before hypophysectomy, and suggests that there is no
progressive benefit with increasing menopausal age beyond 3 years. Besides the
correlation with artificial menopause the other factors can be related to the differ-
ence in survival ofthose with the various intervals between menopause and hypo-
physectomy. First, the proportion of patients with a free interval longer than 5
years was 8% in those still menstruating, 13% in those with menopause less than
3 years before hypophysectomy, and 22% in those with menopause 3 years or more
before hypophysectomy. Secondly, as will be seen later, involvement of lung,
brain or liver by secondary neoplasm carries a poor prognosis; and in the above
3 groups the incidence of such involvement was 58%, 34% and 28% respectively.
Sites of secondary growth.-In Table IV are listed the actual incidences of
growth in the different sites, so that most patients are included under more than
one heading.
There were 184 patients with bone secondaries, and their survival rate at 1
year was 33.5% regardless ofwhatever other sites were involved; when those who
also had deposits inlung, brain and liver are excluded from this group, the survival
in the 136 remaining was nearly 40%. The list shows how secondaries in various
sites affects survival, falling progressively as the other breast, lymph nodes,
pleura, brain and liver wereinvolved, and only 11% ofthosewithlung involvement
survived a year.
Age at hypophysectomy.-None of the 16 women between 20 and 39 years old
survived a year. On the other hand, an unexpected finding was a survival rate
of 50% of those aged 60 to 69 years. Several factors seem to be associated with
the high survival in this group. First, all the women were of course more than
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3 years post-menopausal. Secondly, the incidence of secondary involvement of
the lung, brain, or liver was low, being 22.8% compared with 44% in the 6th
decade, 37% in the 5th decade, and 69% in the 3rd and 4th decades. Finally,
the free interval tended to be shorter for those in their 3rd, 4th and 5th decades
compared with the older women (the interval was less than 3 years in 87% of
patients in their 3rd and 4th decades, in 65% ofpatients in their 5th decade, and
in 56% of those in their 6th and 7th decades).
Death was due to causes other than the neoplasm in 18 cases of the whole
series. Three of these were over 70 years old (17%). In other age groups these
deaths affected from 3 to 8%, the lowest figure being for those in their 7th decade.
Previous hormone treatment.-There were 175 patients who had received some
form of hormone treatment before hypophysectomy. This group includes those
undergoing oophorectomy with or without adrenalectomy, and these receiving
androgens or oestrogens.
The results suggest that those who previously responded to hormone treatment
may live longer than those who did not respond. Of special interest were the 12
patients who had previously undergone adrenalectomy with oophorectomy;
eight ofthese had responded, and in 3 ofthese 8 the subsequent hypophysectomy
was followed by a further period of clinical improvement with regression of skin
metastases in one case. These 3 cases died 3, 12 and 15 months after their hypo-
physectomy.
Of 44 patients who had had oophorectomy without adrenalectomy 13 had
responded; four of these improved again after subsequent hypophysectomy.
Interval between oophorectomy and hypophysectomy.-Where menopause is a
therapeutic step in the history of breast cancer a long interval between it and
subsequent hypophysectomy reflects either hormone dependence ofthe tumour or
a slow rate of tumour growth, or both. Therefore the longer this interval the
longer should be the survival after hypophysectomy. The survival figures are in
accord with this: thus oophorectomy had been previously performed on 56, (of
whom 12 had also had adrenalectomy); the 1 year survival rate ofthis group was
27%. Ofthese 56, the interval between oophorectomy and hypophysectomy was
over 3 years in 22 and the survival rate was 42%. The other 34 patients had their
artificial menopause within the preceding 3 years, a factor already shown to have
a bad prognosis.
Histological grade of malignancy.-In a group of 97 patients the grade of
histological malignancy (Bloom, 1950) was assessed by one ofus (B.P.H.). There
were 20 patients with the most benign histology (grade I), their survival rate at 1
year was 43%. The remainder-77 patients with grade II, III and IW--had
survival rate of 27%.
As might be expected, patients in whom there was a longer interval between
the discovery of the first metastasis and the eventual hypophysectomy had a
better survival rate.
Sensitivity of the tumour to hormone stimulation.-In 19 patients of this series
the effect ofandrogens and oestrogens upon the uptake ofradio-active phosphorus
was measured, using a technique previously described by our colleague Hale
(1961). In 14, subsequent response to hypophysectomy was correctly predicted;
these results form part of a larger group still being studied and some results have
already been published (Hale, 1963, 1966).
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Post-Operative Factors
The effects of some post-operative factors on survival rates are shown in
Table V.
Clinical changes after operation.-There were very much better survival rates
for both patients whose physical signs improved (66.7%) and for those whose
symptoms improved (58-3%) compared with patients without clinical improve-
ment. Where there was obvious deterioration in signs or symptoms from metast-
ases the survival rates were about 6% at one year.
Radio-active iodine uptake.-Eighty-three patients had 48 hour radioactive
iodine uptake measurements over the thyroid gland from between 11 days and
3 weeks after hypophysectomy; (except for 8 who died shortly after hypophysec-
tomy, these patients were the first 83 to be treated). The purpose of this was to
see if a fall in thyroid activity, reflecting a more radical hypophysectomy, could
be related to any better effect of the hypophysectomy on the tumour. It was
therefore a surprise to find that the 1 year survival for those with an uptake ofless
than 25% was not significantly different from the survival for those with an uptake
of 25% or more, and that the figures even seemed to favour those with the higher
uptake. (Both figures were above average because of the exclusion of some
patients dying shortly after hypophysectomy.) The 2 groups however were not
strictly comparable.
In contrast, patients with the lower post-operative 131J uptakes did have a
slightly better rate ofreliefoftheir symptoms; but the groups studied were small
and the differences found could be due to chance.
If this is a true finding then it is not clear why patients in whom thyroid
function is most depressed after hypophysectomy should have a higher rate of
remission of symptoms and signs, yet live no longer than the average.
Use of thyroxine and pitressin after operation.-It might be thought that the
need for thyroxine or the prolonged use ofpitressin would reflect a more complete
hypophysectomy and that this might be reflected in better survival figures.
Differences in accord with this idea were in fact found, but they were small and
could have easily occurred by chance.
Degree ofpituitary ablation.-It must be obvious that removal ofthe pituitary
gland may not always be complete. Evidence on this can be obtained in various
ways:
From the studies ofradioactive iodine uptake 59 (or 71%) of 83 patients at the
beginning of the series had an uptake in the neck of less than 25% at 48 hours.
Eight patients failed to have radioactive iodine uptake measurement because they
died in the immediate post-operative period. Even if all these were assumed to
have an uptake of more than 25% the incidence ofpatients with uptakes less than
25%would be 65%. Thissuggeststhat atleast 65% of the patientshadmore than
95% of their pituitary tissue removed or destroyed (Frazer and Joplin, 1960).
Thyroxine replacement, in those living at least 6 months, was given to 56% of
those operated on in the first 2- years of the period of study, and to 62% in the
second period. The difference between these percentages is not significant and
suggests that the degree ofpituitary ablation achieved has not changed.
Of 12 patients, examined post-mortem, serial sections of the decalcified
pituitary fossa revealed no remained pituitary tissue in 6; some identifiable gland
remnants were found in the others. That in some cases functioning gland remains
3
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post-operatively is borne out by the fact that 3 of 24 pre-menopausal patients
continued to menstruate and 1 conceived.
The anatomy of the sphenoidal sinus affects the ease of access to the pituitary
fossa, the subseller sinus being the least difficult; but the survival rates 1 year after
operation were no better in patients with this anatomy than the average.
Occasionally at hypophysectomy the gland appeared to come out complete in
one piece. More often it had to be removed piecemeal. There were 29 occasions
when the gland appeared to come out whole, and it might have been thought that
hypophysectomy was more likely to be complete in these women, but the results
were almost the same as the averages for the whole group.
DISCUSSION
Benefit from the operation may be assessed by two main criteria: first,
regression of the tumour, with relief of symptoms or improvement in physical
signs; secondly, the prolongation oflife. In this series both criteria were studied,
and in the main there wasgood correlation between the two. This good correlation
has been shown before (McCalister et al., 1961; Boesen, Smith and Baron, 1961;
Riskaer, Munthfog and Hommelgaar, 1961; MacDonald, 1962; Joplin, 1965).
But to use regression of the tumour has certain formidable disadvantages. Thus
it entails much post-operative radiological examination, and the reliefofsymptoms
is open to bias by patient and observer. On the other hand a criticism of using
survival time as the criterion of success or failure is that patients coming to
hypophysectomy are not all at a similar stage in their disease. In the present
group all patients came to hypophysectomy in a late stage of disseminated breast
cancer and in most of thein hypophysectomy was the last resort in treatment.
There are also fallacies in comparing mean survival times for different groups
of patients. In order to avoid these, survival after hypophysectomy has been
calculated by the method of survival tables; this method allows one to make the
best use of results in patients studied over varying periods of time but it is most
laborious even with the help of a computer.
Most of our findings support statements of other studies; some however are
different.
(a) Three other reports show a good correlation between the length of the
"free interval " and response to hypophysectomy (Atkins et al., 1960; Pearson
and Ray, 1960; MacDonald, 1962). Two further groups have reported the same
(Edelstyn, Gleadhill and Lyons, 1964; Boesen et al., 1961).
(b) Unlike the present results other individual figures so far published do not
show a strong correlation between timing of the menopause and response to
hypophysectomy; however when these figures from the literature are collected
together 5900 ofthe 97 pre-menopausal women responded, whereas only44% ofthe
438 post-menopausal women responded (Baron, Gurling and Smith, 1958; Luft
et al., 1958; Evans et al., 1959; Pearson and Ray, 1960; McCalister et al., 1961).
The chance ofthis being a coincidence was less than 1 in 100. Our figures are not
in keeping with these, but show, with equal statistical significance, that those more
than 3 years post-menopausal have a better 1 year survival rate than the remainder.
(Only 24 of our patients were pre-menopausal.) Pearson and Ray (1960) demon-
strated a trend towards an increasing remtission rate with increasing menopausal
age.
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(c) In the present series, patients with bone metastases had a better 1 year
survival rate than average, especially when those with visceral metastases were
excluded. McCalister and others (1961) also showed a much better remission rate
in those with bone metastases than in those with soft tissue or visceral metastases
only. A later review of the Belfast patients supported this finding (Edelstyn
et al., 1965). MacDonald (1962) has also shown the same significant correlations
between site of metastasis and response to hypophysectomy.
(d) The high survival rate for those in their 7th decade at hypophysectomy has
not been shown before. Edelstyn and others (1965) have found a better rate of
remission over the age of 40 years. Pearson and Ray (1960) found no correlation
between age and response until after the menopause when the better response
rate reflected increasing menopausal age. Joplin (1965) found no correlation
between age and response in 53 patients treated by yttrium-90 implantation.
(e) In this series, patients in whom the tumour had previously responded to
endocrine treatment had a better 1 year survival rate than average, this applies
both to those having other ablative operations and to those receiving hormone
therapy but our figures did not reach statistical significance at the 5% level.
Edelstyn and others (1965) hadlikewise reported asignificantly better response rate
in those who had previously responded to oophorectomy or androgen treatment
than in those who had not. Pearson and Ray (1960) found that three-quarters of
those responding to androgen treatment responded to hypophysectomy, and that
90% of 21 women responding to oophorectomy subsequently responded to hypo-
physectomy. In three series on the other hand (Atkins et al., 1960; Boesen et al.,
1961; Joplin, 1965) no significant correlation was found between response to
previous hormone treatment and response to pituitary ablation.
(f) There have been no reports of a significant correlation between the histo-
logical appearance ofthe primary tumour and response to hypophysectomy. The
present report shows a better 1 year survival rate for those women with tumour
showing the most benign histological appearance, but the figures are based on only
97 of our patients and the results do not reach statistical significance.
(g) McCalister and others (1961) reported that when the hypophysectomy is
performed within 6 months ofthe tumour becoming widespread, the response rate
was better than if the operation were delayed longer. Subsequent studies from
the same centre (Edelstyn et al., 1964) failed to confirm this. In the present
series when this period was less than 1 year the 1 year survival rate was 30%.
Survival rate fell to 25% when this period was 1 to 3 years and then improved
again with further lengthening of the period.
In summary, there is the evidence in the present study and in the literature that
five factors are fairly well established as favouring a good response to hypophysec-
tomy. These are, (i) a long " free interval ", (ii) either pre-menopausal hypo-
physectomy or several years after the menopause, (iii) performing the operation
in the 7th decade, (iv) when secondary deposits are in the bone rather than viscera,
and (v) a previous favourable response to androgens or oophorectomy.
Although these five factors are a guide to prognosis after hypophysectomy, if
their absence were used inmaking a decision againsthypophysectomy in individual
cases some of these cases would be denied the chance ofremission. Joplin (1965)
reports 2 patients with papilloedema who had complete clinical remissions. One
woman in the present series who hadpapilloedema at the time ofhypophysectomy
was well 44 months later, and another with severe dyspnoea and papilloedema
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survived 13 months. It has been felt in Bristol that all women offered for hypo-
physectomy should be given the chance of remission and the decision to operate
has not been influenced by the five factors mentioned above.
In the present series, two sequels to the hypophysectomy are of interest. (1)
Following trans-sphenoidal hypophysectomy, the incidence of diabetes insipidus
fell with increasing age, being 75% in young women, and only 22% in those over
70 years old. This phenomenon has not been reported. (2) The other sequel was
the excessive gain in weight of 8 women, accompanied by a great hunger in 2, and
prolonged diabetes insipidus in 4; it seems likely that these 8 patients had had
some damage to the hypothalamus.
SUMMARY
1. The results are presented oftrans-sphenoidal hypophysectomy for advanced
breast cancer in 258 women.
2. The relation of various pre-operative and post-operative factors to the
outcome have been examined.
3. The results are discussed and related to other published series.
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